ALIM Stock Data and Insider Activity
ALIM - Alimera Sciences, Inc. Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology. The company expects to accelerate growth of ILUVIEN through increased penetration of existing markets; expansion into new markets; and a new indication for non-infectious posterior uveitis in the EU.
  
     
Chart and Financial Data provided by TradingView
Whale Activity

Recently reported position changes by institutional investors

No data for this ticker
Senate Trading

Recent trades by U.S. Senators

No data for this ticker
House Trading

Recent trades by U.S. Representatives

No data for this ticker
Insider Trading

Quarterly net insider trading by a company's directors and management

Corporate Flights

Flights by private jets registered to ALIM

No data for this ticker
Government Contracts

Federal grants, loans, and purchases. Click on a date for more info.

Date Agency Amount

2021-08-27 00:00:00

2021-08-27 00:00:00
DEPARTMENT OF VETERANS AFFAIRS (VA) $0
Twitter